NASDAQ:IOSP - Innospec Stock Price, Price Target & More

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

Innospec declared a semiannual dividend on Wednesday, May 9th. Investors of record on Monday, May 21st will be paid a dividend of $0.44 per share on Thursday, May 31st. This represents a yield of 1.18%. The ex-dividend date is Friday, May 18th. This is a boost from Innospec's previous semiannual dividend of $0.39. View Innospec's Dividend History.

Innospec Inc. (NASDAQ:IOSP) released its earnings results on Tuesday, May, 8th. The specialty chemicals company reported $1.02 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.91 by $0.11. The specialty chemicals company earned $360.70 million during the quarter, compared to the consensus estimate of $308.90 million. Innospec had a return on equity of 14.91% and a net margin of 4.86%. The company's revenue was up 22.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.00 EPS. View Innospec's Earnings History.

Innospec is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for Innospec.

3 analysts have issued 12 month price objectives for Innospec's shares. Their predictions range from $65.00 to $86.00. On average, they expect Innospec's share price to reach $75.50 in the next twelve months. This suggests that the stock has a possible downside of 8.5%. View Analyst Ratings for Innospec.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Innospec include Chemours (CC), Huntsman (HUN), W. R. Grace & Co (GRA), Ashland Global (ASH), Olin (OLN), Ingevity (NGVT), Univar (UNVR), Balchem (BCPC), PQ Group (PQG), GCP Applied Technologies (GCP), KMG Chemicals (KMG), OCI Partners (OCIP), Innophos (IPHS), Nexeo Solutions (NXEO) and Hawkins (HWKN).

News articles about IOSP stock have trended somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Innospec earned a news impact score of 0.19 on Accern's scale. They also gave media headlines about the specialty chemicals company an impact score of 46.51 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Innospec's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Kirr Marbach & Co. LLC IN (0.75%), Xact Kapitalforvaltning AB (0.02%), Capital One National Association (0.02%) and First Citizens Bank & Trust Co. (0.01%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Joachim Roeser, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Institutional Ownership Trends for Innospec.

IOSP stock was sold by a variety of institutional investors in the last quarter, including Kirr Marbach & Co. LLC IN. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Insider Buying and Selling for Innospec.

IOSP stock was bought by a variety of institutional investors in the last quarter, including Capital One National Association, First Citizens Bank & Trust Co. and Xact Kapitalforvaltning AB. View Insider Buying and Selling for Innospec.

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of IOSP stock can currently be purchased for approximately $82.50.

Innospec has a market capitalization of $2.02 billion and generates $1.31 billion in revenue each year. The specialty chemicals company earns $61.80 million in net income (profit) each year or $4.66 on an earnings per share basis. Innospec employs 1,900 workers across the globe.

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]